Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)
Clinical trial NCT03743428 · SUSPENDED
Trial details
- NCT number
- NCT03743428
- Sponsor
- Shenzhen People's Hospital
- Status
- SUSPENDED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2025-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.